T he cystic fibrosis transmembrane conductance regulator (CFTR) plays a crucial role in maintaining fluid secretion of epithelial cells of the airways and the intestine. Defective CFTR leads to an imbalance between fluid absorption and secretion in the lungs of cystic fibrosis (CF) patients, resulting in a relatively dehydrated mucus layer on the airways. However, the onset of clear symptoms of impaired lung function remains highly variable. A striking contrast can be found when one examines the exocrine pancreas. Among all CF patients, 7090% are born with pancreatic insufficiency, which means that >98% of the pancreatic capacity is already lost (17). Even in the seemingly pancreatic-sufficient patients, the ratio between alkaline fluid and secreted digestive enzymes is significantly decreased (8). Clinicians have been using the amount of residual pancreatic function to classify CF patients into severe and mild cases. Under physiological conditions, the secreted HCO 3 -rich fluid and electrolytes serve to flush the digestive enzymes from the acini and ducts of the pancreas. Thus impaired HCO 3 secretion results in poor clearance of the digestive enzymes, and their premature activation eventually causes the destruction of the pancreas in CF. During the past few years, it has been shown that a similar defect in HCO 3 secretion can also be found in the small and large intestine (16) and, surprisingly, also in the airway mucosa (18). We would assert that a similar sequela as in the pancreas follows from impaired HCO 3 secretion in the submucosal glands and airways of CF patients. Analogous to the pancreas, the submucosal glands secrete mucins, protease inhibitors, antibiotic peptides, and enzymes that must be flushed from the glands onto the airway surface epithelium. Moreover, the physical properties of mucus are intrinsically dependent on the electrolyte composition of the fluid. Thus the results of recent studies on submucosal gland serous cells should provide important new insights into the mechanism of HCO 3 secretion in airway epithelial cells and have significant implications in the future treatment of CF.
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HCO 3 secretion in the exocrine pancreas
The human pancreas is the most severely affected organ in the onset of CF. Patients with CF exhibit a variety of symptoms that are related to pancreatic insufficiency or even the lack of secretion of pancreatic juice. The enzymes secreted by the acinar cells of the pancreas and targeted for the small intestine remain stuck in the ducts, leading to subsequent destruction of the pancreatic tissue. In most of the pancreatic-insufficient patients, the tissue damage has already taken place in utero; however, in some cases the process may develop over a period of many years. Pancreatic insufficiency leads to maldigestion and severe steatorrhea, with concomitant loss of lipid-soluble vitamins and essential fatty acids. The malnutrition renders the patients more susceptible to infections, thus also aggravating the lung symptoms of the patients. Fortunately, the deficiencies of pancreatic insufficiency can be surmounted in large measure by dietary supplementation.
The exocrine pancreas consists of two morphologically distinct structures: 1) acinar cells that secrete enzymes, mucins, and NaCl and 2) duct cells that mainly secrete a HCO 3 -rich fluid. The cause for the pancreatic insufficiency in CF has been attributed to a lack of ductal function, whereas the acinar cells show only small or no abnormalities at all. Thus it was no surprise that immunocytochemical studies localized CFTR almost exclusively to the pancreatic ductal cells, although a few reports demonstrated some scanty expression in the acinar cells. The general concept of ductal fluid secretion has been developed over the past 60 years. Bro-Rasmussen and colleagues (1) were among the first to correlate the HCO 3 concentration with the secretory output of the pancreas after stimulation with the hormone secretin, a cAMP-mediated agonist (1) . The observed inverse correlation between the HCO 3 and the Cl content of the pancreatic juice can now be found in most textbooks of physiology. In a series of elegant experiments on perfused pancreatic ducts (13), Ivana Novak and Rainer Greger demonstrated that the ductal epithelial cell uses a unique mechanism for its secretory functions. The simplified model in Fig. 1 depicts their basic hypothesis for ductal HCO 3 secretion.
HCO 3 ions are generated from CO 2 that enters the cell from the basolateral side by passive diffusion. The activity of carbonic anhydrase in the duct cell catalyzes the formation of carbonic acid from CO 2 and H 2 O and the subsequent dissipation into HCO 3 and protons. The latter are extruded through the basolateral membrane via a secondary active Na + /H + exchanger. The driving force for the antiporter is provided by the Na + pump, establishing the concentration gradient for Na + . Basolateral K + channels maintain a hyperpolarized basolateral membrane. For a number of species, an additional Na + -dependent HCO 3 uptake mechanism on the basolateral mem- ions that are accumulated by these mechanisms leave the cell on the apical membrane via a disulfonic stilbene-sensitive pathway in exchange for Cl . To this end, the molecular identity of this anion exchanger (AE) in the pancreatic duct has not yet been identified. The classic AE1 that was first identified in the red blood cell and the other members of this family (AE2 and AE3) are not expressed on the apical membrane of HCO 3 -secreting epithelial cells. Other proteins like downregulated in adenoma (DRA; SLC26A3), (19) pendrin (SLC26A4), and a member of the putative anion transporter family (PAT1; SLC26A6) have been implicated as likely candidates for this mechanism (12) . The Cl ions required for the exchange process are provided by the Cl -rich acinar fluid and are recycled via luminal Cl channels. The concerted actions of apical Cl channels and basolateral K + channels create a lumen-negative transepithelial voltage that draws Na + and H 2 O across the epithelium into the lumen. The proposed mechanism might explain the earlier finding that with increasing HCO 3 secretion the concentration of Cl decreases. It also highlights the crucial role of CFTR in this mechanism. The seeming void of any other Cl export mechanisms ties the function of the AE inseparably to the only Cl channel detected in the apical membrane of this epithelium, which is considered to be CFTR. A defect in the luminal Cl conductance would eventually abolish both HCO 3 and fluid secretion.
Does CFTR directly regulate anion exchange?
The coupling between HCO 3 transport and CFTR has recently been reinvestigated (10) , and it was postulated that the activity of the putative AE per se is regulated by CFTR and is not dependent on Cl movement through the channel. On the basis of the observation that some mutations in the CFTR gene render CF patients pancreatic sufficient but most others do not, Choi and coworkers (2) expressed selected CFTR mutations in fibroblasts. In the subsequent functional studies, the authors recognized that some of the mutations showed an apparent lack in their HCO 3 transport, as assessed by the rate of alkalinization in Cl -free medium, whereas the Cl transport (detected by a Cl -sensitive fluorophore) seemed to be unaffected and vice versa. The comparison of the results in the expression system with clinical data yielded an interesting correlation. Mutations that led to impaired HCO 3 transport in the expression system were only found in the pancreaticinsufficient patients, and those mutations that solely produced a decreased Cl conductance were found in pancreatic-sufficient patients. The authors proposed that the impaired HCO 3 transport resulted from a disruption between CFTR and the anion exchange mechanism and therefore could be held responsible for the fatal pathogenesis in CF in all tissues expressing both proteins. This work has drawn quite a bit of attention toward the field of HCO 3 transport. Nevertheless, the results of this study should be regarded with caution. Some carriers of mutations that were seemingly associated with an intact Cl conductance did have abnormal sweat Cl concentrations, indicative of an impaired Cl permeability in the sweat duct (20) . Moreover, whereas the coupled AE/Cl conductance model is applicable for the rat pancreas where the maximal HCO 3 concentration is ~70 mmol/l, it is not sufficient to explain why the human pancreas is able to secrete almost isotonic (140 mmol/l) NaHCO 3 . Recent experiments performed on pancreatic ducts of guinea pigs, a species in which the HCO 3 concentration of the pancreatic juice is similar to that of humans, revealed that the model depicted in Fig.  1 might need to be revised. In guinea pigs the basal HCO 3 secretion is dependent on the luminal Cl concentration. However, the cAMP-stimulated secretion is unaffected by the removal of luminal Cl . This observation indicated the presence of a Cl -independent conductive pathway for HCO 3 in the luminal membrane of pancreatic duct cells. On the basis of these data, a modified hypothesis on ductal HCO 3 and fluid secretion in the distal ducts of the exocrine pancreas was proposed ( Fig. 2) (7, 14) .
Does CFTR conduct HCO 3 ?
The exact nature of the luminal HCO3-exit pathway in pancreatic ducts is still under debate. A body of evidence initially pointed in the direction of CFTR. Several studies to date have addressed the question of whether CFTR per se conducts HCO3-. Table 1 summarizes the findings of these studies. Together these data suggest that CFTR does have a finite permeability for HCO 3 ions, but this permeability is at best 26% of that for Cl ions. At this point, it seems justified to question whether this seemingly low permeability might in fact be sufficient to permit HCO 3 transport through CFTR. Possibly the answer to this question can be found in a tissue that was generally not considered to secrete HCO 3 ions: the airways.
HCO 3 secretion in the airways
In the past decade, a few studies on primary cultures of human bronchial epithelial cells derived from non-CF and CF patients undergoing lung transplant have demonstrated that non-CF cells secrete HCO 3 and that HCO 3 secretion is impaired in CF cells (3, 18) . In non-CF cells, amiloride causes a 5070% decrease in the short-circuit current (I sc ). The residual I sc requires HCO 3 and not Cl in the bathing solution and is partially inhibited by serosal DNDS, a disulfonic stilbene that blocks HCO 3 transporters. cAMP causes a further increase in the I sc , and this increase requires HCO 3 in the bathing solution and is inhibited by serosal DNDS. Thus non-CF cells display a basal level of HCO 3 secretion, and this can be stimulated by cAMP. In CF cells, amiloride inhibits nearly all of the I sc and cAMP fails to cause an increase in the I sc . Studies of this nature led Smith and Welsh (18) to conclude that HCO 3 secretion is impaired in CF airway epithelia and that HCO 3 exit at the apical membrane is through the anion channel that is defectively regulated in CF epithelia (18) .
Secretion of airway serous cells: lessons from Calu-3 cell studies
Airway epithelia can be divided in two different functional entities: primarily absorptive cells and secretory cells. The absorptive surface epithelia of the airways express high levels of the epithelial Na + channel (ENaC), whereas the CFTR expression is rather scanty. In contrast, the secretory serous cells of the submucosal glands lack ENaC expression and have been demonstrated to be the predominant site of CFTR expression in the airways, expressing manyfold higher levels of CFTR compared with the surface airway epithelium. Recent studies on an airway serous cell line, Calu-3, have provided further support that airway cells secrete HCO 3 in response to cAMP (4, 9) . Calu-3 cells resemble the characteristics of airway serous cells and can be grown as polarized monolayers for transport studies. Thus the Calu-3 cells have served as a model for airway serous cells, and studies with the Calu-3 cells have provided important insight into the underlying mechanisms of HCO 3 secretion. Calu-3 cells display a low basal I sc that increases upon stimulation with forskolin. Isotope flux studies revealed that the forskolin-stimulated I sc was not the result of net Cl , Na + , or K + transport, leaving HCO 3 secretion as the likely basis of the I sc . Ion substitution studies showed that the forskolin-stimulated I sc did not require Cl in the mucosal or serosal bathing solutions but did require serosal HCO 3 and serosal Na + . Bumetanide, an inhibitor of the Na
cotransporter, also failed to block the forskolin-stimulated I sc . In contrast, serosal DNDS, but not mucosal DNDS, partially inhibited the forskolin-stimulated I sc . These results led us to conclude that Calu-3 cells secrete HCO 3 by an electrogenic mechanism in response to forskolin stimulation. We proposed that HCO 3 influx across the basolateral membrane was mediated by a DNDS-sensitive Na + -HCO 3 cotransporter (NBC). HCO 3 exit across the apical membrane did not require luminal Cl , nor was it inhibited by mucosal DNDS. Thus we proposed that HCO 3 exit was mediated by CFTR.
The switch from HCO 3 to Cl secretion: driving force matters An important feature of anion secretion by the Calu-3 cells was revealed by the use of 1-ethyl benzimidazolone (1-EBIO).
1-EBIO activates Ca

2+
-activated K + channels such as hIK-1, but unlike with agonists like acetylcholine the activation of the K + channels is prolonged. The addition of 1-EBIO to forskolinstimulated Calu-3 cells caused a further increase in the I sc , as expected for the activation of basolateral membrane K + channels and the hyperpolarization of the membrane potential. However, in contrast to stimulation with forskolin alone, stimulation with forskolin plus 1-EBIO caused the net secretion of Cl as revealed by isotope flux studies and the inhibition of the I sc by bumetanide. Indeed, the I sc of forskolin plus 1-EBIOstimulated cells was fully accounted for by the net secretion of Cl . Figure 3 illustrates these findings. The activation of basolateral K + channels caused Calu-3 cell anion secretion to switch from HCO 3 secretion to Cl secretion. These results led us to propose that the basolateral membrane NBC was an electrogenic transporter carrying a greater number of HCO 3 anions than Na + cations. Hyperpolarization of the basolateral membrane potential as a result of the activation of K + channels by 1-EBIO would tend to inhibit HCO 3 influx across the basolateral membrane. Indeed, if the basolateral membrane potential were to exceed the reversal potential of the NBC, HCO 3 might exit rather than enter the cell across the basolateral membrane. Concomitant with the inhibition of an electrogenic NBC, the Na
cotransporter is activated in forskolin plus 1-EBIO-stimulated cells.
Consistent with the very high levels of CFTR expression, forskolin causes the apical membrane resistance to fall to a remarkably low value. At the same time we observe a depolarization of the apical membrane to the equilibrium potential for Cl . This effect is so dominant that it also depolarizes the basolateral membrane due to the low shunt resistance of the paracellular pathway. The activation of basolateral membrane K + channels by forskolin, as is evident from the decrease in the basolateral membrane resistance upon forskolin stimulation, is insufficient to maintain the basolateral membrane potential.
Instead the basolateral membrane depolarizes, and this provides a favorable membrane potential for HCO 3 entry on an electrogenic NBC. Whether forskolin also activates the NBC via PKA-mediated phosphorylation is not known at this time. Thus the very high apical membrane anion conductance stimulated by forskolin 1) serves to mediate the conductive exit of HCO 3 , 2) sets the driving force for HCO 3 exit across the apical membrane, and 3) sets the driving force for the entry of HCO 3 across the basolateral membrane on the NBC. As expected for the activation of basolateral membrane K + channels by 1-EBIO, the basolateral membrane and apical membrane potentials are seen to hyperpolarize from their forskolin-stimulated values. The hyperpolarization of the apical membrane would be expected to increase the driving force for both HCO 3 and Cl exit and thus cannot explain the inhibition of HCO 3 secretion. However, the hyperpolarization of the basolateral membrane potential is expected to inhibit the influx of HCO 3 mediated by an electrogenic NBC that moves a net anionic charge. The removal of Na + or HCO 3 from the serosal solution or the addition of DNDS both result in the depolarization of the basolateral membrane potential, as expected for an electrogenic NBC (Tamada, Hug, and Bridges, unpublished observations). Indeed, one may deduce from the basolateral membrane potential measurements in forskolin and forskolin plus 1-EBIO-stimulated cells that the Na + -HCO 3 stoichiometry of the NBC in Calu-3 cells is 1:3. On the basis of these observations, we proposed a model for anion secretion by airway serous cells that is depicted in Fig.  4 .
Summary
The studies with Calu-3 cells establish an electrochemical profile against which results from submucosal gland serous cells can be compared to determine whether native serous cells secrete anions in a similar manner. If our results with Calu-3 cells are representative of airway serous cells, then HCO 3 secretion in the airways may be more important than has previously been appreciated. In addition, these studies and our proposed model for HCO 3 and Cl secretion by the same cell may help explain the pathophysiology of anion secretion in the pancreas and small intestine of CF patients. If our model is correct, CFTR serves as the conductive pathway for HCO 3 exit across the apical membrane in HCO 3 -secreting cells. Mutations in CFTR that impair the conductance of the channel for HCO 3 are expected to increase the severity of the disease in those epithelia where HCO 3 secretion is essential for the normal physiology of the organ. Impaired HCO 3 secretion in the pancreas and small intestine in CF patients has been known for many years. The results with primary cultures of human bronchial epithelial cells and Calu-3 cells suggest that HCO 3 secretion may also be important in the airways. It seems prudent to speculate that a similar mechanism to that found in Calu-3 cells might be attributable to other epithelia that secrete HCO 3 .
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